Date of first dose
Item
Date of first dose of imatinib mesylate received:
date
C3173309 (UMLS CUI-1)
Date of last dose
Item
Date of last dose of imatinib mesylate received:
date
C1762893 (UMLS CUI-1)
HIGHEST DOSE
Item
Highest dose of imatinib mesylate received (in mg):
float
C1522410 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Item
Subject is eligible due to:
text
C1548635 (UMLS CUI-1)
Code List
Subject is eligible due to:
CL Item
Primary resistance (1)
CL Item
Acquired resistance (2)
TOLERABLE DOSE
Item
Has the subject ever tolerated a dose of imatinib mesylate greater than or equal to 600mg?
boolean
C3658296 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
Item
Reasons for intolerance:
text
C1744706 (UMLS CUI-1)
Code List
Reasons for intolerance:
CL Item
Fluid retention (1)
CL Item
Gastrointestinal symptoms (2)
CL Item
Arthralgia/ Myalgia (3)
Specification
Item
If other, please specify:
text
C2348235 (UMLS CUI-1)
Item
Best hematologic response to imatinib mesylate:
text
C0205488 (UMLS CUI-1)
C0871261 (UMLS CUI-2)
C0939537 (UMLS CUI-3)
Code List
Best hematologic response to imatinib mesylate:
CL Item
Complete hematologic response (CHR) (1)
CL Item
Return to chronic phase (RTC) (2)
CL Item
No evidence of Leukemia (NEL) (3)
CL Item
No response to imatinib mesylate (4)
HEMATOLOGIC PROGRESSION DATE
Item
Date of most recent hematologic progression while on imatinib mesylate:
date
C0011008 (UMLS CUI-1)
C0449258 (UMLS CUI-2)
C0205488 (UMLS CUI-3)
DOSE
Item
Imatinib mesylate dose at time of most recent hematologic progression (in mg):
float
C0450442 (UMLS CUI [1,1])
C0677800 (UMLS CUI [1,2])
C1521941 (UMLS CUI [1,3])
C1521801 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,5])
Item
Best cytogenetic response to imatinib mesylate:
text
Code List
Best cytogenetic response to imatinib mesylate:
CL Item
Complete cytogenetic response (CCyR) (1)
CL Item
Partial cytogenetic response (PCyR) (2)
CL Item
Minor cytogenetic response (3)
CL Item
Minimal cytogenetic respose (4)
CL Item
No response to Imatinib mesylate (5)
DATE
Item
Date of most recent cytogenetic progression while on imatinib mesylate:
date
C0011008 (UMLS CUI-1)
DOSE
Item
Imatinib mesylate dose at time of most recent cytogenetic progression (in mg):
float
C0450442 (UMLS CUI [1,1])
C0677800 (UMLS CUI [1,2])
C1521941 (UMLS CUI [1,3])
C1521801 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,5])